NNG Share Price Performance
zł2.71
-1.17 (-30.28%)
Price zł2.71
fis_wse
Share Pricezł2.71
NanoGroup S.A. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 12 Fair Values set on narratives written by author
NNG Community Narratives
FI
Fair Value zł0 n/aintrinsic discount
Expect big change: Nanogroup's NanOX system will tackle global kidney shortages
0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
NanoGroup S.A. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.22
- Gross Margin
- -212,459.00%
- Net Profit Margin
- -7,000,663.00%
- Debt/Equity Ratio
- 0%
NanoGroup S.A. Competitors
Snowflake Analysis
About NNG
- Founded
- 2016
- Employees
- n/a
- CEO
- WebsiteView website
NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Polish Market Performance
- 7 Days: 1.3%
- 3 Months: -0.7%
- 1 Year: 25.9%
- Year to Date: 27.0%
The market has climbed 1.3% in the last 7 days, lead by the Financials sector with a gain of 2.9%. The market is up 26% over the last 12 months. Looking forward, earnings are forecast to grow by 16% annually. Market details ›